vs
Side-by-side financial comparison of DIODES INC (DIOD) and Bio-Techne (TECH). Click either name above to swap in a different company.
DIODES INC is the larger business by last-quarter revenue ($391.6M vs $295.9M, roughly 1.3× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs 2.6%, a 10.2% gap on every dollar of revenue. On growth, DIODES INC posted the faster year-over-year revenue change (15.4% vs -6.4%). Over the past eight quarters, DIODES INC's revenue compounded faster (13.9% CAGR vs 4.2%).
Diodes Incorporated is a global semiconductor manufacturer that designs, produces and supplies discrete, analog and mixed-signal semiconductor products. Its solutions serve key end markets including automotive, industrial, consumer electronics, personal computing and communications infrastructure, with a worldwide customer base.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
DIOD vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $391.6M | $295.9M |
| Net Profit | $10.2M | $38.0M |
| Gross Margin | 31.1% | 64.6% |
| Operating Margin | 3.4% | 18.4% |
| Net Margin | 2.6% | 12.8% |
| Revenue YoY | 15.4% | -6.4% |
| Net Profit YoY | 23.8% | 68.3% |
| EPS (diluted) | $0.23 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $391.6M | $295.9M | ||
| Q3 25 | $392.2M | — | ||
| Q2 25 | $366.2M | $317.0M | ||
| Q1 25 | $332.1M | $316.2M | ||
| Q4 24 | $339.3M | $297.0M | ||
| Q3 24 | $350.1M | $289.5M | ||
| Q2 24 | $319.8M | $306.1M | ||
| Q1 24 | $302.0M | $303.4M |
| Q4 25 | $10.2M | $38.0M | ||
| Q3 25 | $14.3M | — | ||
| Q2 25 | $46.1M | $-17.7M | ||
| Q1 25 | $-4.4M | $22.6M | ||
| Q4 24 | $8.2M | $34.9M | ||
| Q3 24 | $13.7M | $33.6M | ||
| Q2 24 | $8.0M | $40.6M | ||
| Q1 24 | $14.0M | $49.1M |
| Q4 25 | 31.1% | 64.6% | ||
| Q3 25 | 30.7% | — | ||
| Q2 25 | 31.5% | 62.7% | ||
| Q1 25 | 31.5% | 67.9% | ||
| Q4 24 | 32.7% | 65.3% | ||
| Q3 24 | 33.7% | 63.2% | ||
| Q2 24 | 33.6% | 66.4% | ||
| Q1 24 | 33.0% | 67.4% |
| Q4 25 | 3.4% | 18.4% | ||
| Q3 25 | 3.0% | — | ||
| Q2 25 | 2.6% | -7.5% | ||
| Q1 25 | 0.4% | 12.2% | ||
| Q4 24 | 3.5% | 16.0% | ||
| Q3 24 | 6.2% | 13.8% | ||
| Q2 24 | 1.2% | 15.0% | ||
| Q1 24 | 4.3% | 22.1% |
| Q4 25 | 2.6% | 12.8% | ||
| Q3 25 | 3.6% | — | ||
| Q2 25 | 12.6% | -5.6% | ||
| Q1 25 | -1.3% | 7.1% | ||
| Q4 24 | 2.4% | 11.7% | ||
| Q3 24 | 3.9% | 11.6% | ||
| Q2 24 | 2.5% | 13.3% | ||
| Q1 24 | 4.6% | 16.2% |
| Q4 25 | $0.23 | $0.24 | ||
| Q3 25 | $0.31 | — | ||
| Q2 25 | $0.99 | $-0.11 | ||
| Q1 25 | $-0.10 | $0.14 | ||
| Q4 24 | $0.18 | $0.22 | ||
| Q3 24 | $0.30 | $0.21 | ||
| Q2 24 | $0.17 | $0.26 | ||
| Q1 24 | $0.30 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $377.0M | $172.9M |
| Total DebtLower is stronger | $25.7M | $260.0M |
| Stockholders' EquityBook value | $1.9B | $2.0B |
| Total Assets | $2.4B | $2.5B |
| Debt / EquityLower = less leverage | 0.01× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $377.0M | $172.9M | ||
| Q3 25 | $386.4M | — | ||
| Q2 25 | $327.3M | $162.2M | ||
| Q1 25 | $343.9M | $140.7M | ||
| Q4 24 | $316.1M | $177.5M | ||
| Q3 24 | $319.3M | $187.5M | ||
| Q2 24 | $273.9M | $152.9M | ||
| Q1 24 | $276.0M | $145.3M |
| Q4 25 | $25.7M | $260.0M | ||
| Q3 25 | $24.9M | — | ||
| Q2 25 | $26.4M | $346.0M | ||
| Q1 25 | $20.5M | $330.0M | ||
| Q4 24 | $20.7M | $300.0M | ||
| Q3 24 | $22.2M | $300.0M | ||
| Q2 24 | $20.3M | $319.0M | ||
| Q1 24 | $20.9M | $389.0M |
| Q4 25 | $1.9B | $2.0B | ||
| Q3 25 | $1.9B | — | ||
| Q2 25 | $1.9B | $1.9B | ||
| Q1 25 | $1.8B | $2.0B | ||
| Q4 24 | $1.8B | $2.1B | ||
| Q3 24 | $1.8B | $2.1B | ||
| Q2 24 | $1.8B | $2.1B | ||
| Q1 24 | $1.7B | $2.0B |
| Q4 25 | $2.4B | $2.5B | ||
| Q3 25 | $2.5B | — | ||
| Q2 25 | $2.5B | $2.6B | ||
| Q1 25 | $2.4B | $2.6B | ||
| Q4 24 | $2.4B | $2.7B | ||
| Q3 24 | $2.4B | $2.7B | ||
| Q2 24 | $2.4B | $2.7B | ||
| Q1 24 | $2.4B | $2.7B |
| Q4 25 | 0.01× | 0.13× | ||
| Q3 25 | 0.01× | — | ||
| Q2 25 | 0.01× | 0.18× | ||
| Q1 25 | 0.01× | 0.16× | ||
| Q4 24 | 0.01× | 0.14× | ||
| Q3 24 | 0.01× | 0.14× | ||
| Q2 24 | 0.01× | 0.15× | ||
| Q1 24 | 0.01× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $38.1M | — |
| Free Cash FlowOCF − Capex | $12.4M | — |
| FCF MarginFCF / Revenue | 3.2% | — |
| Capex IntensityCapex / Revenue | 6.6% | — |
| Cash ConversionOCF / Net Profit | 3.74× | — |
| TTM Free Cash FlowTrailing 4 quarters | $137.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $38.1M | — | ||
| Q3 25 | $79.1M | — | ||
| Q2 25 | $41.5M | $98.2M | ||
| Q1 25 | $56.7M | $41.1M | ||
| Q4 24 | $81.8M | $84.3M | ||
| Q3 24 | $54.4M | $63.9M | ||
| Q2 24 | $14.4M | $75.5M | ||
| Q1 24 | $-31.1M | $81.0M |
| Q4 25 | $12.4M | — | ||
| Q3 25 | $62.8M | — | ||
| Q2 25 | $21.1M | $93.3M | ||
| Q1 25 | $40.8M | $31.0M | ||
| Q4 24 | $62.1M | $77.5M | ||
| Q3 24 | $39.4M | $54.7M | ||
| Q2 24 | $-3.5M | $57.5M | ||
| Q1 24 | $-51.5M | $64.5M |
| Q4 25 | 3.2% | — | ||
| Q3 25 | 16.0% | — | ||
| Q2 25 | 5.8% | 29.4% | ||
| Q1 25 | 12.3% | 9.8% | ||
| Q4 24 | 18.3% | 26.1% | ||
| Q3 24 | 11.2% | 18.9% | ||
| Q2 24 | -1.1% | 18.8% | ||
| Q1 24 | -17.1% | 21.3% |
| Q4 25 | 6.6% | — | ||
| Q3 25 | 4.2% | — | ||
| Q2 25 | 5.6% | 1.5% | ||
| Q1 25 | 4.8% | 3.2% | ||
| Q4 24 | 5.8% | 2.3% | ||
| Q3 24 | 4.3% | 3.2% | ||
| Q2 24 | 5.6% | 5.9% | ||
| Q1 24 | 6.7% | 5.4% |
| Q4 25 | 3.74× | — | ||
| Q3 25 | 5.54× | — | ||
| Q2 25 | 0.90× | — | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | 9.93× | 2.42× | ||
| Q3 24 | 3.95× | 1.90× | ||
| Q2 24 | 1.80× | 1.86× | ||
| Q1 24 | -2.22× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DIOD
| Distributor | $253.1M | 65% |
| Direct Sales | $138.5M | 35% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
